GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kyorin Pharmaceutical Co Ltd (OTCPK:KYRNF) » Definitions » Net Investment Income

Kyorin Pharmaceutical Co (Kyorin Pharmaceutical Co) Net Investment Income


View and export this data going back to 2013. Start your Free Trial

What is Kyorin Pharmaceutical Co Net Investment Income?

Net Investment Income only applies to insurance companies.


Kyorin Pharmaceutical Co (Kyorin Pharmaceutical Co) Business Description

Traded in Other Exchanges
Address
6, Kanda Surugadai 4-chome, Chiyoda-ku, Tokyo, JPN, 101-8311
Kyorin Pharmaceutical Co Ltd is engaged in manufacturing and sale of pharmaceutical products. The company manages its business in two reportable segments namely Pharmaceutical Business and the Consumer Healthcare (Skincare) Business. The Pharmaceutical business focuses on producing and selling ethical drugs, generic drugs and over-the-counter drugs. The Consumer Healthcare (Skincare) Business mainly sells and purchases skincare products. The company's products include Kipres, for treating bronchial asthma and allergic rhinitis; Mucodyne, a mucoregulant; Pentasa, for treating ulcerative colitis and Crohn's disease; and Uritos, for treating overactive bladder. Majority of the company's revenue comes from domestic sales.